19 February 2016 - Deborah Wilkes
Archived
Perrigo's chairman and chief executive officer Joseph Papa described the performance of the company's European OTC business in the fourth quarter of 2015 as a "personal disappointment". He said Perrigo was taking specific actions to address the problem, including plans to "exit slower growing or underperforming brands" such as the Etixx sports-drink range.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.